BHB, WP1066, and IP-Se-06 were found to directly inhibit glioma migration, proliferation, and viability by inhibiting the expression or activity of the NLRP3 inflammasome in glioma [127–129]. This evidence concerns the gene NLRP3 and central nervous system cancer.